Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)

Funding Opportunity PAR-20-158 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support high risk, high impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. In keeping with the high risk, high impact nature of this research, this FOA supports a Go/No-Go approach to funding high risk research, which is significantly different from most R01 projects. Continued funding for the full award duration is dependent upon achieving negotiated Go/No-Go criteria by the end of Year 2.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding